Real-time enrollment status for this secondary progressive multiple sclerosis clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 9:22 AM UTC
| NCT Number | NCT07299019 |
| Recruiting Status | Recruiting |
| Condition | Secondary Progressive Multiple Sclerosis |
| Phase | PHASE3 |
| Target Enrollment | 990 participants |
| Active Locations | 21 sites in the US |
| Sponsor | Zenas BioPharma (USA), LLC |
| Last Updated on CT.gov | August 25, 2026 (2 days ago) |
As of August 27, 2026: Clinical trial NCT07299019 is currently recruiting participants. This phase3 study for secondary progressive multiple sclerosis is actively seeking new participants at 21 locations across the United States. The study is sponsored by Zenas BioPharma (USA), LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07299019 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 21 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07299019 was last updated 2 days ago (August 25, 2026). HelloStudys verifies this status automatically.